9 September, 2016 - 09:20Reducing NHS mental health care waiting times and budgets via secure online video counselling (#2121)The launch of TOSPS (The One Stop Psychotherapy Shop) as an online secure platform from which therapy can be both sought & delivered lends itself to a real opportunity to revolutionise the way face-to-face crisis mental health therapy is delivered to people in need, in any location via the introduction of a crisis care platform.
It is vital that people have an opportunity to be assessed as quickly as possible before a crisis point is reached, therefore the development of a minimum interaction app to compliment the TOSPS web site is vital to ensure that people in (or approaching) a crisis are connected to a therapist quickly.
Background applications can enable complicity with NHS, Local Authority & 3rd sector mental health service provider’s requirements & interact with the digital systems records, booking systems within one application. An affordable application that is nondependent on any particular proprietary platform.
Early detection trigger guidelines allow quick diagnosis & referral to treatment for the client. Alerts to service users, carers & professionals when risks of crisis within individuals are elevated, prompting a call from a therapist or practitioner where applicable.
This app ensures that getting help & or treatment is as simple as ordering a pizza, To assist users, all of our registered therapists display our unique “on-line” light showing that they are available right now to provide instant help. The app can analyse stress triggers & alert people to potential looming issues, & seek early prevention treatment & can link to applications such as iHealth & S Health.
Payment modules can be adapted for pre-booked appointments or after event payments. Some people may wish to approach things methodically & be directed to the Mother web site, others who are in advanced crisis can be connected to immediate help via the app. The security protocols are already developed to reach current IGSoC compliance HIPAA & peer to peer security is established.
5 September, 2016 - 12:44Improving patients with diabetes outcomes on injectable therapies (#2118)It is intended that this work will develop:
- A framework for both the NMS and MUR consultation for community pharmacists on injectable therapies in diabetes. To include safe administration, safety, including appropriate quantities of insulin adn adherence.
- Pharma outcomes will be used to support framework and implementation of project. This will also enable commissioners to understand the quality of the interactions from pharmacy.
- Develop an education framework for pharmacists to deliver injectable therapy NMS and MUR.
- Upskill community pharmacists around the pilot site to deliver patient support for injectable therapies via NMS and MUR.
- Process map current and future state for MUR service.
- Measure outcomes to show the value of interventions.
31 August, 2016 - 10:46Inhaler Training Aids (#2114)Flo-Tone MDI (also known as Flo-Tone CR) uses a ‘Positive’ Coaching Whistle to help patients learn to inhale SLOWLY and STEADILY. Whistle Signal is a prompt for the canister to be pressed releasing the medication & the duration of the Whistle helps the professional to coach the patient towards correct use.
Pressurised inhaler mouthpieces come in a variety of shapes, accordingly Flo-Tone was originally produced in ‘Circular’ & ‘Regular’ Models. A new improved Flo-Tone CR now fits all mouthpiece shapes by fitting inside the pMDI mouthpiece. The new design ensures all pMDIs produce a whistle at the same flow rate, helping standardise technique.
Studies have been conducted with the new Flo-Tone to ensure that it delivers the full dose. The first study detailing the development of the improvement & its performance was presented at BTS 2015 & subsequently at DDL26.
Available on prescription, the improved Flo-Tone CR can be used with a pMDI simulator (Trainhaler) for training & with the Patient pMDI. It incorporates a cap so that it can be left in situ on the Inhaler. It also includes a rim on the mouthpiece to help patients get their teeth out of the way of the aerosol spray.
We have tested Flo-Tone CR with a variety of inhaled medications (Flutiform, Clenil, Ventolin, QVAR and Sirdupla) – in each case the respirable dose (ie that part that reaches the lungs) delivered for the medication plus Flo-Tone closely matched that of the device alone & in each case unwanted throat deposition was reduced.
•Flo-Tone CR controls the resistance of the pMDI, thereby standardising the flow rate at which
Flo-Tone CR whistles
•Provide inhalation & coordination guidance
•Sounds (20-25 L/min)
•Drug delivery improvement = Therapeutic Improvement
•Less throat deposition – potentially less unwanted Throat Side-Effects
•Better control - less breakthrough – less SABA needed
•Better control – less hospitalisation
• Spacer & Mask with anti-Microbial & anti-static properties
• Collapsible – helps with storage & travel
• Visible valve movement - see that the drug is being Inhaled
• Suitable for adults & children
• Performance validated with pMDI’s
• Accepts all pMDI’s available
• Available with small & medium mask
• Ideal for emergency services use, schools & within General Practice & Hospitals for reversibility testing
• Single patient use
• Economical & environmentally friendly
• Performance validated with pMDI’s
• Available in bulk pack
30 August, 2016 - 12:26GiveVision (#2112)According to European blind Union age-related eye conditions are the most common cause of sight loss in Europe with One in three senior citizens over 65 facing sight loss. A common misconception is that blind persons cannot see anything at all. This is of course true for some but there are four times as many partially sighted, as there are completely blind. What’s worse is that existing sight aid solutions don’t give real independence to older adults living with sight loss. Industry haven’t seen any innovation in 25 years and is still limited to magnifying glasses and CCTV systems.
SightPlus, enables partially sighted people to see again by combining real time video augmentation with heads-up display technology to leverage their remaining sight. The tool empowers partially sighted people to be able to see faces of their loved ones, read printed and digital text, recognise signs and objects at a distance, watch TV and stay connected over the web.
SightPlus is built on existing hardware platform (i.e. Android smartphone and VR headset) resulting in a scalable and much more affordable product compared to existing tools. It can also communicate with a wide range of other smart devices as it has embedded connectivity. For purposes of immediate assistance and tech support - all of our devices come with a 4G SIM card to ensure that our customer stay connected even when there is no WiFi network available.
Our technology is designed to offer new ways for visually impaired people to interact and experience the world around them, unlock their independence and mobility, and significantly increase their quality of life by empowering them to continue to lead independent lives and play an active role in society, whether that be at home, work, education, or in their community.
16 August, 2016 - 11:59BVI Assessment Tool – For the instant determination of percentage and distribution of Visceral Fat (#2105)The Body Volume Indicator (BVI) is a new measurement for healthcare and obesity. After eight years of successful and innovative validation from scientific collaborators around the world, BVI is now undergoing final testing prior to a full launch later in 2016.
Using 3D technology, BVI calculates risk factors associated with a person's body shape, by measuring weight and body fat distribution, with particular focus on the abdomen; the area associated with the greatest risk.
BVI is designed to be a long-term addition to the Body Mass Index (BMI); the current recognised standard for measurement of obesity. The intention is for the Body Volume Indicator to become a Body Volume Index by 2020, by which time sufficient data will have been collected globally. Using smartphone technology, BVI data can now be collected anywhere with web or internet access.
Body Volume, as an indicator of health, offers a potential long-term solution as a measure of individual health risk.
BVI was developed in the West Midlands and collaborators have included Heartlands Hospital, Aston University, Mayo Clinic and the Medical Research Council. The application was patented in the US in 2012 and throughout Europe in 2015.
In 2012 Select Research obtained exclusive use of the largest and most comprehensive collection of Body Composition Data (BCD) of visceral fat data from MRI scans in the world. This has been used to develop an App which will be used to scan/photograph lightly clothed patients and then comparing their BCD database to predict their body fat and visceral fat.
Further research and development is being undertaken with our current BVI (Body Volume Index) tool, to provide additional evidence and to validate the efficacy, and appropriateness of this BVI application in real-life environments. Through a ‘real-life’ project work with WMAHSN will provide clinical validation for the underpinning methodology, thus making potential users (Clinicians, patients & public) aware of the benefits (social and economic) of utilising the service.
Thus our current BVI application is to be incorporated into the existing patient pathways currently used by Health Exchange Health Trainers in the West Midlands.
NB: The application has been patented in the US in 2012 and throughout Europe in 2015 and covers all measurements of part body volume for healthcare from a 3D scan. Body fat is a part volume of the human body.
Please assist us with our 5 min Survey http://BVISurvey.SSIsurveys.com
6 August, 2016 - 11:18WellBrum (#2099)The budgets being prepared now by councils show that soon in many communities there will be no money for anything except adult social services. It’s not just libraries and swimming pools that will go - it is many core wellbeing services including for young people, safety, transport, homelessness, addiction, and a lot more. The impact on communities will be huge - so where is the safety net?
In 2014 the Chief Economist of the Bank of England released figures showing that the total amount of volunteering in the UK is equivalent to 10% of all paid hours worked, which has an economic and social value of at least £100 billion per year. However, community groups struggle to engage with public services, with each other, and with the public. Councils could mitigate the impact of austerity by helping their communities release more value from volunteering. Even for a small community, just a small improvement in the effectiveness of volunteering is worth millions of pounds per year - and can make a huge difference to local wellbeing.
WellBrum is based on Town Digital Hub - a non-profit cloud platform that allows councils to create online “collaboration plans” for helping members of the public achieve personal goals related to each wellbeing Issue they face (Activity, Eating, Helping, Meeting, Learning, Work, Safety, Transport, Drugs & Alcohol, and Culture). The stakeholders in each collaboration plan are your local council, community groups, and usually some businesses - they use the hub to show what they provide to help you reach your wellbeing goals. You can rate and review their contributions, and include the ones you find useful in your personal "wellness plan".
That’s it - collaboration plans are simple, effective, and usually most of the information required to create them already exists. But the value is huge in addressing wellbeing, especially in a time of austerity - both from enabling service providers to reduce gaps/overlaps in provision, and from enabling the public to use local services to achieve their personal wellbeing goals.
And increasing wellbeing not only saves money for health and social care but has major impact on local regeneration and resilience. WellBrum can help provide a safety net for austerity by unlocking the massive value of community initiatives and integrating them together with NHS and council services into holistic personal wellness plans.
For more information, see http://bit.ly/tdh-psycap.
4 August, 2016 - 08:33New 3D scaffold for biodegradable cardiac patch (#2095)Cardiac patch is a scaffold structure compatible with in-vitro cell seeding & cell culture used as a vector for cellular therapy in addition to structural support. Numerous applications include curettage & cardiac transmural use in addition to soft tissue engineering such as hernias & vein repair. Scaffold composition comprises poly(caprolactone), alginate & composites thereof with natural polymers such as chitosan & alginate fibroin decorated with a synthetic peptidic hydrogel. Porosity can be tailored with pore range of 10-250µm, permitting angiogenesis and cell seeding. Although the biomaterial can be used independently as a medical device for prosthetic applications, its main tissue engineering function is to enhance cell attachment, growth & differentiation. An extension of the device is its functionalisation with cell signalling agent capacity providing the scaffold with extracellular matrix like micro-environment. Polymeric self-assembled structure is composed of but not limited to peptidic or polyurethane amphiphiles & can be loaded with chemical & biological cues covalently or via entrapment.
To initiate regeneration, the biomaterial must encourage in-vivo revascularisation & promote integration with host tissue. Concurrently, it should biodegrade at the same rate that newly formed tissue replaces it, being removed from the body by natural metabolic pathways without toxic by-products.
The patch provides both a temporary mechanical support to the infarcted myocardium preventing further damage to the surrounding tissue and prevents aneurism formation in the infarcted area whilst regeneration take place
Myocardial infarct treatment
Device can be used for in-vitro & in-vivo applications. Both parts of the device can be loaded with cell signalling agents or drugs for research & clinical use. Fibre based secondary drug delivery structure allows multiple growth factor/drug release with different release profiles as a direct tool for gel functionalisation with patient blood components in-vivo.
The system’s mechanical properties match the tissue it replaces. 3D hydrophobic/hydrophilic scaffold provides mechanical support to a gel that acts as scaffold plasticizer & provides an hydrophilic interface with host environment. The gel can also collect cell signalling agents from its immediate environment. The electrospun fibre based drug delivery system can additionally be used as a complementary tool to the gel for loading with cell signalling agents, drugs etc
3 August, 2016 - 17:08Rosie Runciman (#2094)The Sound Doctor is the leading provider of film and audio content for patients in the UK. Our content is thought to be unmatched in quality, range and production values and evaluations show it works by changing behaviours.and improving outcomes to help people get the best out of life with long term conditions.
Our films are endorsed by leading charities and adhere to NICE guidelines.
Conditions covered are COPD, Diabetes, back pain, dementia and weight management surgery. A large series on heart conditions including cholesterol and hypertension, will be made shortly.
There are over 250 films in our library so far and it is constantly growing.
We also create animations. We have a range of health and wellness short animations which are now being used in pharmacies and GP surgeries around the country.
In addition, the team also devised and produce Health Today, a national radio programme for NHS England – nhs.uk/healthtodayradio
We have evidence that patients with diabetes, for example, have changed their attitudes towards diet and exercise as a result of watching our films. People with COPD are more confident about dealing with exacerbations at home. We also know that across all conditions they are considered a valuable part of people’s health care and improve patient experience.
The aims of The Sound Doctor, and there is evidence of this as well, are:
1. To reduce the number of avoidable admissions (and readmissions) to hospital
2. To reduce the need for face to face contact with consultants, physicians, nurses, physiotherapists and others (and to improve the quality of meetings which do take place)
3. To address the issue of co-morbidities by creating a multi-condition library
4. To improve medicines management and compliance with medications
5. To improve the quality of care for patients (and patient experience of their care)
6. To help people get the most out of life through effective self-management
The Sound Doctor was founded by Dominic Arkwright and Rosie Runciman.
Dominic worked as a reporter at the BBC for more than 20 years, mostly on Radio 4 's Today Programme as well as Newsnight and PM. He also presented discussion programme 'Off the Page' and 'The Call' on Radio 4.
Rosie Runciman also worked at the BBC for more than 20 years on Radio 4's Today programme, Newsnight, Radio 5 Live and at The World Service. She was Editor of Newshour and Assistant Editor at Five Live.
3 August, 2016 - 10:07LiverMultiScan – non-invasive MRI technology to aid clinicians in the diagnosis of early liver disease (#2091)Perspectum Diagnostics is a medical imaging company with an ISO 13485 compliant CoreLab. The company has developed novel imaging technology, LiverMultiScan, an MRI-based non-invasive tool that has attained CE-marking and FDA 510(k) clearance to aid the diagnosis of patients with chronic liver disease.
LiverMultiScan (and LiverMultiScan Discover for clinical trial use) can characterise liver tissue in three ways, providing accurate measurements of liver fat, hepatic iron content and fibro-inflammatory disease, using the proprietary Liver Inflammation and Fibrosis (LIF) score. The LIF score has been shown to stratify NAFLD and NASH patients (Pavlides, 2015), correlate with histological markers of inflammation and fibrosis (Banerjee, 2014), and most importantly, is the first imaging test to predict liver-related clinical outcomes (Pavlides, 2016). It is the only liver imaging technology included in the UK Biobank study, with 100,000 scans to be performed in the coming years (Kelly, 2015).
Available as a Quantitative Analysis Service (QAS), LiverMultiScan has been cleared as an imaging tool to aid the diagnosis of early liver disease. It offers a standardised and high-quality method for supporting Gastroenterology/Hepatology and Radiology departments in diagnosis and monitoring of the liver in clinical settings and studies, and has potential to streamline clinical management by compressing the diagnostic pathway. Perspectum is also supporting multiple international clinical trials with LiverMultiScan Discover.
- Banerjee et al. (2014) Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease. J Hepatol. 60:69-77.
- Kelly et al. (2015) Predicted prevalence of NAFLD and NASH in a large population using non-invasive multiparametric MRI. AASLD 2015. Abstract ID: 931.
- Pavlides et al. (2015) Multi-parametric magnetic resonance can accurately assess NAFLD histological disease severity; comparison with transient elastography. AASLD 2015. Abstract ID: 2190.
- Pavlides et al. (2016) Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease. J Hepatol. 64:308-315.
2 August, 2016 - 09:06TAPREVENT - long term condition multi-morbidity monitoring and coaching (#2089)http://www.therapyaudit.com/TA/TAPREVENT.mp4
TAPREVENT is a software-based monitoring and coaching solution for patients living with long term conditions. It comprises the established and proven TAMONITOR 'control centre' software used by clinicians or administrators and the new MyDocInPoc (MDIP) app-based solution for patients. Using the two systems together enables clinicians to enroll their patients on monitoring and coaching programmes, and patients to send vital signs readings to their clinician for automatically checking and, if necessary, escalation by TAMONITOR. In addition appropriate coaching and advice can be provided to patients as warranted by rules set up by the clinicians within TAMONITOR. The knowledge base facility within TAMONITOR enables clinicians to build a resource of advice that can be automatically and/or manually sent to patients in response to their submitted readings.
TAPREVENT is initially developed to support people living with diabetes, as part of a project in China. The TAPREVENT capability will enable additional LTCs to be added to both TAMONITOR and MDIP, so that patient with multi-morbidities can be supported from within the one MDIP app.
TAMONITOR also has a workflow capability which focuses 'practitioners' (clinicians and/or administrators) on the jobs they need to attend to that day. This enables performance monitoring of the practitioner.
TAPREVENT is based on the proven TAMONITOR monitoring system used in some NHS hospitals for over 17 years. The inclusion of MDIP extends the collection of vital signs to patients, providing an important element of self-care and self-management. Although the system has been built in response to specific requirements from China, the system should be easily transferrable to the NHS. THERAPYAUDIT welcomes involvement from NHS clinicians and patients in evaluating this new approach.
1 August, 2016 - 10:43Qlic Tablet Stand with Charging Facilities (#2088)
Qlic is a Universal tablet stand with charging capabilities. Qlic has several models; cable suitable for both apple and android tablets, simply plug the charging cable into your device and plug the power supply unit to the wall. Our QI patch receiver can enable most devices for wireless charging. Insert the connecter to the charging point on your device, stick the patch to the rear and pop your tablet or phone back into its case (compatible with cases up to 5mm thick).
Qlic was designed to save time for tablet users as well as to provide a more ergonomically suitable solution for people who use mobile devices on a daily basis.
We believe that as mobile devices become more and more popular within care settings Qlic will help to support the working environment within NHS trusts.
Qlic was originally developed to support the learning environment within schools and has proven to be very popular within educational settings (please see our product video - https://www.youtube.com/watch?v=Cepvxf07oU8).
After looking into the NHS and the use of mobile devices we thought that Qlic would be ideal for NHS settings as well. Not only will Qlic save time and effort, you won't need to think about charging the device as simply placing the device on the cradle will enable charging to begin. We looked at the use of mobile devices and thought that our stand would be ideal on nurses stations, for use by clinical leads, office staff, ambulances and drug trolleys as our stand can also be permanently fixed to surfaces.
We would like to find out the type of tablets/ mobile devices and the type of protective cases currently used to ensure that our stand is suitable for all. We would also like suggestions on where you think our product would be most suitable for use? Where would Qlic make your life easier?
27 July, 2016 - 15:24Community created Emergency, Critical and Advance Care Plans (#2085)MyDirectives.com and MyDirectives mobile gives every consumer the opportunity to record their digital voice for free. The service uses structured forms, video and audio messages to create high quality documents that health professionals trust to use to make best interest decisions. The service then encourages people to share their wishes with people they trust to support them in a crisis or if they cannot speak for themselves. Thos "agents" are sent education packs and urged to have conversations. Then MyDirectives works with local health economies to integrate the consumer's wishes with primary, secondary and local authority databases/electronic health records so the consumer knows their voice will always be accessible. For health professionals this also means they can be confident they are looking at the most up to date views of their patients, know who can speak for the patient and what their goals and objectives are. This approach is human and highly disruptive. It leads to better and quicker decision making and can be scaled through MyDirectives' API to the whole community. MyDirectives is a not just for profit company that charges health economies for marketing and integration. The benefits of this pro-active approach are significant cash releasing savings that we can evidence. An indication of how much this approach might save a health economy is a bill currently going though both houses of the US Congresss that proposes to give every US citizen on medicaid and medicare £75 in return for creating a digital emergency, critical and advance care plan. MyDirectives has been life for four years and is used by individuals in 34 countries around the world. We are now looking for our first health care partner in the UK. We want a partner who can work with us to set up a UK integration network with the GP suppliers, the summary care record and the organ donor list and an adoption strategy using GP suppliers, secondary care providers, E-referrals, the organ donor register and NHS Choices. We believe we can create a national system of adoption and retrieval using the NHS existing infrastructure. The end result will be a cost effective mechanism for recording and retrieving a patient's voice.